InSite Vision Announces Court Judgment Upholding All AzaSite® Patents in Patent Infringement Lawsuit Against Sandoz, Inc.

Published: Oct 07, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that the United States District Court for the District of New Jersey upheld all four of the patents protecting AzaSite® (azithromycin 1% ophthalmic solution) in a patent infringement lawsuit against Sandoz Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news